4th Annual Patient Recruitment and Retention in Clinical Trials

13-15 October 2008, Amsterdam

Patient recruitment is now consuming thirty percent of clinical trial time - more time than any other clinical trial activity - and almost half of all trial delays result from patient recruitment problems. As the recruiting culture becomes more sophisticated and the forces affecting patient enrollment grow more numerous and complex, pharmaceutical companies are striving to discover new strategies to facilitate enrollment in clinical trials. With increasing industry pressure to develop, test and market greater numbers of new drugs faster, pharmaceutical companies need to perform clinical trials as quickly as possible. Inefficient patient recruitment processes is a formidable barrier to pharmaceutical companies' success in launching new products. Improving the patient recruitment process is imperative to avoid wasted investments and eliminate costly delays in bringing new drugs to market -- today and even more so in the not-so-distant future. Improved patient recruitment presents one of the largest opportunities for pharmaceutical companies to eliminate delays in clinical trials, thereby making it possible to reduce time to market.  With patent time limits and large overheads meaning that any delays in the development timeline can be disastrous, a good understanding of how to successfully recruit patients for trials is vital for any company looking to succeed.
More info >>

Dr James Thomson to lead new Stem Cell and Regenerative Medicine Center within the new Morgridge Center for Discovery on UW-Madison campus

By Tom Still MADISON – There’s no one alive today who was around to witness the birth of Wisconsin’s dairy and cranberry industries in the late 1800s, or its rise as a manufacturing power in roughly the same era. But a new page in Wisconsin’s history of commerce is being written in our time – the emergence of stem-cell medicine. Recent events have solidified Wisconsin’s edge as a global leader in stem-cell research and the breakthroughs in human health it will produce (continued):
More info >>